Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary triglycerides and other dietary lipids are the primary form of fat consumed in the human diet, serving as a major energy source and providing essential fatty acids and fat-soluble vitamins (StatPearls: Physiology, Triglycerides, 2023). These lipids, primarily triacylglycerols, undergo emulsification by bile salts and enzymatic hydrolysis by lipases in the gastrointestinal tract to be absorbed as free fatty acids and monoglycerides (NIH: Lipids and Health, 2022). Pathologically, the overconsumption or dysregulated metabolism of dietary lipids is a key contributor to the development of obesity, atherosclerosis, and metabolic syndrome (Mayo Clinic: Triglycerides, 2023). Therapeutic strategies do not target the lipids themselves but rather the enzymes and transporters responsible for their digestion and absorption, such as pancreatic lipase and NPC1L1, to manage weight and lipid profiles (FDA: Xenical Prescribing Information). By modulating the availability of these lipids, drugs can effectively lower systemic lipid levels and reduce caloric intake, though this often results in gastrointestinal side effects related to lipid malabsorption (PubMed: Lipid-lowering drugs, 2021).
Drugs targeting the processing of dietary lipids typically act by inhibiting gastric and pancreatic lipases (e.g., Orlistat) to prevent the hydrolysis of triglycerides into absorbable free fatty acids, or by inhibiting specific transporters like NPC1L1 (e.g., Ezetimibe) to block cholesterol uptake (PubMed: Lipid-lowering drugs, 2021). Other agents, such as bile acid sequestrants, bind bile acids in the intestine, preventing the emulsification and subsequent absorption of dietary fats (StatPearls: Bile Acid Sequestrants, 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary triglycerides and other dietary lipids.